Eurofins Viracor Expands Cytokine Testing Portfolio
LENEXA, Kan., July 16, 2026 Eurofins Viracor has expanded its immunology testing portfolio with the launch of three new...
Clinical Trials for New Therapy
Moderna Doses First Patient in mRNA-4200 Cancer Trial
CAMBRIDGE, Mass., July 16, 2026 Moderna, Inc. has announced the first participant has been dosed in its Phase 1...
Insmed Reports Positive 12-Month TPIP PAH Study Data
BRIDGEWATER, N.J., July 16, 2026 Insmed Incorporated has announced positive 12-month results from the ongoing open-label extension (OLE) study...
Intensity Therapeutics Restarts Phase 2 TNBC Trial
SHELTON, Conn., July 15, 2026 Intensity Therapeutics, Inc. has restarted patient treatment in its Phase 2 INVINCIBLE-4 clinical trial...
Cumulus Unveils AI Tool for Alzheimer’s Trial Screening
TORONTO, Canada, July 15, 2026 Cumulus Neuroscience has presented new clinical findings at the Alzheimer’s Association International Conference (AAIC)...
Spinogenix Reports Durable Tazbentetol Alzheimer’s Data
LOS ANGELES, Calif., July 14, 2026 Spinogenix, Inc. has announced encouraging long-term clinical data demonstrating that its investigational therapy...
Kelun-Biotech Reports Phase III Success for sac-TMT in NSCLC
CHENGDU, China, July 14, 2026 Kelun-Biotech has announced a major clinical milestone after its Phase III OptiTROP-Lung06 trial evaluating...
AAIC 2026 Study Shows Blood Test Predicts Alzheimer’s Risk
LONDON, United Kingdom, July 15, 2026 New research presented at the Alzheimer’s Association International Conference (AAIC) 2026 has revealed...
Lexitas and Ocusun Dose First Patient in Cataract Trial
DURHAM, N.C. & GUANGZHOU, China, July 14, 2026 Lexitas Pharma Services and Ocusun have announced the enrollment of the...
Skyhawk Therapeutics Advances Global Phase 2/3 HD Trial
BOSTON, Mass. — July 14, 2026 Skyhawk Therapeutics, Inc. has announced a major expansion of its global pivotal Phase...